Holen Sie sich die Stockscreener-App
2.00
4.17%
0.08
Schlusskurs vom Vortag:
$1.92
Offen:
$1.91
24-Stunden-Volumen:
44,492
Relative Volume:
0.11
Marktkapitalisierung:
$5.40M
Einnahmen:
$832.80K
Nettoeinkommen (Verlust:
$-21.55M
KGV:
-0.166
EPS:
-12.0465
Netto-Cashflow:
$-12.71M
1W Leistung:
-2.91%
1M Leistung:
-34.64%
6M Leistung:
-63.57%
1J Leistung:
-87.60%
1-Tages-Spanne:
$1.89
$2.1518
1-Wochen-Bereich:
$1.85
$2.1518
52-Wochen-Spanne:
$1.8401
$41.20
Hcw Biologics Inc Stock (HCWB) Company Profile
Firmenname
Hcw Biologics Inc
Sektor
Branche
Telefon
954-842-2024
Adresse
2929 N COMMERCE PKWY, MIRAMAR
Vergleichen Sie HCWB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
2.00 | 5.19M | 832.80K | -21.55M | -12.71M | -12.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hcw Biologics Inc Aktie (HCWB) Neueste Nachrichten
HCW Biologics Inc Stock Analysis and ForecastREITs Market Trends & Investment Timing Techniques - earlytimes.in
Will HCW Biologics Inc. stock benefit from sector rotationJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Is HCW Biologics Inc. overvalued or undervalued? - Markets Mojo
HCW Biologics Amends License Agreement with Trimmune - MSN
How HCW Biologics Inc. stock performs in rate cut cyclesQuarterly Earnings Report & Real-Time Volume Analysis - Newser
HCW Biologics (NASDAQ:HCWB) Trading Down 7.1% – Here’s What Happened - Defense World
HCW Biologics (HCWB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Hedge Fund Bets: Why HCW Biologics Inc. stock is seen as undervaluedPortfolio Growth Summary & Weekly Chart Analysis and Guides - BỘ NỘI VỤ
Form 8-KCurrent report - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results - ADVFN
HCW Biologics Inc. (HCWB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HCW Biologics Secures $4M Through Warrant Exercise - MSN
Why HCW Biologics Inc. stock attracts high net worth investorsMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Is HCW Biologics Inc. stock positioned well for digital economyMarket Movers & Safe Entry Trade Reports - newser.com
Will HCW Biologics Inc. stock benefit from infrastructure spending2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
HCW Biologics Begins Phase 1 Trial for HCW9302 - MSN
[8-K] HCW Biologics Inc. Reports Material Event | HCWB SEC FilingForm 8-K - Stock Titan
Insiders' US$3.05m Investments In Red Following HCW Biologics' US$1.1m Dip In Market Value - simplywall.st
What analysts say about HCW Biologics Inc stockSector Rotation Strategies & Low Risk Trading Growth - earlytimes.in
Why retail investors favor HCW Biologics Inc. stockShort Setup & Daily Oversold Stock Bounce Ideas - newser.com
HCW Biologics secures $4 million through warrant exercise agreement By Investing.com - Investing.com Nigeria
HCW Biologics enters amended licensing agreement with Beijing Trimmune Biotech - Investing.com Nigeria
Using fundamentals and technicals on HCW Biologics Inc.Market Performance Recap & Real-Time Volume Surge Alerts - newser.com
Hcw Biologics announces warrant inducement agreement - MarketScreener
HCW Biologics secures $4 million through warrant exercise agreement - Investing.com
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules - The Manila Times
HCW Biologics (NASDAQ: HCWB) Announces $4M Warrant Deal, 3,020,410 New Warrants - Stock Titan
HCW Biologics enters amended licensing agreement with Beijing Trimmune Biotech By Investing.com - Investing.com South Africa
How HCW Biologics Inc. stock reacts to oil pricesPortfolio Performance Summary & Low Risk Entry Point Guides - newser.com
Finanzdaten der Hcw Biologics Inc-Aktie (HCWB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):